NCT05406713
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05406713
Title Pembrolizumab in MIBC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vaibhav Patel
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87102 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field